Company: CCIXW
Filing Date: 2025-12-05
Form Type: S-4/A
Source: 0001193125-25-309933
Chunk: 491

Company: Churchill Capital Corp IX/Cayman
Filing Date: 2025-12-05
Form: S-4/A
Chunk 491
---
. Our non-cash charges primarily consisted of $9.3 million for impairment of long-term investment, $5.9 million loss from a change in fair value of simple agreements for future equity, $5.8 million loss from a change in fair value of warrant liabilities, $1.6 million for non-cash lease expense, $1.5 million for depreciation and amortization of our property and equipment, and a $0.9 million for stock-based compensation. The net change in operating assets and liabilities was primarily due to a $1.8 million decrease in operating lease liabilities, a $0.5 million decrease in accrued and other liabilities, and a $0.4 million decrease in accrued compensation and benefits, partially offset by a $1.9 million increase in accounts payable, a $1.1 million increase in discounted options liability, and a $0.7 million decrease in accounts and other receivables. Net Cash Flows from Investing Activities Net cash used by investing activities for the nine months ended September 30, 2024 was $0.9 million, which primarily consisted of $0.5 million in cash outflows from purchases of short-term marketable securities, and $0.5 million from the purchase of property and equipment, partially offset by maturities of short-term marketable securities of $0.1 million. Net cash provided by investing activities for the nine months ended September 30, 2025 was $17.1 million, which primarily consisted of $18.0 million from the sale of long-term investment in Plus PRC, $0.5 million in the proceeds from maturity of short-term marketable securities, partially offset by $1.0 million from the purchases of property and equipment, and $0.6 million in cash outflows from purchases of short-term marketable securities. Net Cash Flows from Financing Activities Net cash provided by financing activities for the nine months ended September 30, 2024 was $14.0 million, which consisted of $14.0 million from the cash received from the issuance of SAFEs. Net cash provided by financing activities for the nine months ended September 30, 2025 was $2.3 million, which primarily consisted of $2.4 million from the cash received from the issuance of SAFEs and $1.9 million from the exercise of stock options. This amount was offset by $1.4 million repurchase of restricted common stock awards and $0.5 million for the payment of deferred issuance costs